Login to Your Account

Coley Shares Soar on Buyout

Pfizer Boosts Vaccine Pipeline With $164M Deal For Coley

By Donna Young

Monday, November 19, 2007
In an effort to boost its vaccine and biological development pipeline, Pfizer Inc. is acquiring Coley Pharmaceutical Group Inc. in a deal worth about $164 million. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription